Skip to main content
. Author manuscript; available in PMC: 2014 May 3.
Published in final edited form as: J Sleep Disord Treat Care. 2013 Sep 23;2(4):10.4172/2325-9639.1000121. doi: 10.4172/2325-9639.1000121

Table 3.

Test characteristics (95% confidence intervals) for the STOP-BANG measured and STOP-BANG self-reported scores.

AHI>5 AHI>15 AHI>30
STOP-BANG measured
 Sensitivity (95%CI) 82.2% (78.6–85.7) 93.2% (87.3–96.9) 96.8% (88.8–99.4)
 Specificity (95%CI) 48.0% (35.8–59.8) 40.5% (35.3–43.8) 33.1% (30.0–34.2)
 PPV (95%CI) 84.2% (80.5–87.8) 58.2% (54.5–60.5) 36.4% (33.3–37.4)
 NPV (95%CI) 44.4% (33.1–55.4) 87.0% (75.9–94.0) 96.3% (87.1–99.4)
 Odds ratio (95%CI) 4.28 (2.05–8.95) 9.34 (3.77–24.17) 14.86 (3.37–91.50)
 Area under ROC curve (95%CI) .722 (.645–.799) .746 (.682–.811) .762 (.696–.827)
STOP-BANG self-reported
 Sensitivity (95%CI) 79.3% (75.6–82.8) 88.3% (81.9–93.2) 93.5% (84.7–97.9)
 Specificity (95%CI) 50.0% (37.6–62.0) 41.4% (35.7–45.7) 35.7% (32.2–37.4)
 PPV (95%CI) 84.3% (80.4–88.1) 57.2% (53.1–60.4) 36.5% (33.0–38.2)
 NPV (95%CI) 41.7% (31.3–51.7) 80.0% (69.0–88.4) 93.3% (84.2–97.8)
 Odds ratio (95%CI) 3.83 (1.87–7.89) 5.35 (2.52–11.57) 8.04 (2.62–27.55)
 Area under ROC curve (95%CI) .714 (.637–.792) .736 (.670–.802) .758 (.690–.826)